Skip to main content
. 2020 Dec 1;93(4):2262–2269. doi: 10.1002/jmv.26669

Figure 1.

Figure 1

ROC curve analysis of three anti‐SARS‐CoV‐2 immunoassays at more than 2 weeks after the symptom onset (n = 87)